Journal Home
Search for

Volume 50, Issue 5, Pages 1106-1113 (November 2009)


View previous. 28 of 73 View next.

Treatment of recurrent varicose veins of the great saphenous vein by conventional surgery and endovenous laser ablation

Laura van Groenendael, MDa, J. Adam van der Vliet, MD, PhDc, Lizel Flinkenflögel, MDa, Elisabeth A. Roovers, PhDb, Steven M.M. van Sterkenburg, MDa, Michel M.P.J. Reijnen, MD, PhDaCorresponding Author Informationemail address

Received 27 May 2009; accepted 27 June 2009.

Objective

Varicose vein recurrence of the great saphenous vein (GSV) is a common, costly, and complex problem. The aim of the study was to assess feasibility of endovenous laser ablation (EVLA) in recurrent varicose veins of the GSV and to compare this technique with conventional surgical reintervention.

Methods

Case files of all patients treated for GSV varicosities were evaluated and recurrences selected. Demographics, duplex scan findings, CEAP classification, perioperative data, and follow-up examinations were all registered. A questionnaire focusing on patient satisfaction was administered.

Results

Sixty-seven limbs were treated with EVLA and 149 were surgically treated. General and regional anesthesia were used more in the surgery group (P < .001). Most complications were minor and self-limiting. Wound infections (8% vs 0%; P < .05) and parasthesia (27% vs 13%; P < .05) were more abundant in the surgery group, whereas the EVLA-treated patients reported more delayed tightness (17% vs 31%; P < .05). Surgically-treated patients suffered less postoperative pain (P < .05) but reported a higher use of analgesics (P < .05). Hospital stay in the surgery group was longer (P < .05) and they reported a longer delay before resuming work (7 vs 2 days; P < .0001). Patient satisfaction was equally high in both groups. At 25 weeks of follow-up, re-recurrences occurred in 29% of the surgically-treated patients and in 19% of the EVLA-treated patients (P = .511).

Conclusion

EVLA is feasible in patients with recurrent varicose veins of the GSV. Complication rates are lower and socioeconomic outcome is better compared to surgical reintervention.

a Department of Surgery, Division of Vascular Surgery, Alysis Zorggroep, Location Rijnstate, Arnhem, The Netherlands

b Clinical Research Department, Alysis Zorggroep, Location Rijnstate, Arnhem, The Netherlands

c Department of Surgery, Division of Vascular Surgery, University Medical Centre Nijmegen, Nijmegen, The Netherlands

Corresponding Author InformationReprint requests: Michel M.P.J. Reijnen, MD, Department of Surgery, Alysis Zorggroep, Location Rijnstate, Wagnerlaan 55, 6815 AD Arnhem, The Netherlands

 Competition of interest: none.

PII: S0741-5214(09)01363-9

doi:10.1016/j.jvs.2009.06.057


View previous. 28 of 73 View next.